Skip to main content

and
  1. Article

    Open Access

    Exome sequencing reveals recurrent REV3L mutations in cisplatin-resistant squamous cell carcinoma of head and neck

    Dacomitinib, an irreversible pan-HER inhibitor, had shown modest clinical activity in squamous cell carcinoma of head and neck (SCCHN) patients. Therefore, validated predictive biomarkers are required to ident...

    Kie Kyon Huang, Kang Won Jang, Sangwoo Kim, Han Sang Kim in Scientific Reports (2016)